Finance

Lists
Why is BNGO down 6,27%?
Dive Deeper
BNGO:NASDAQ
BioNano Genomics Inc
1,34 USD
-6,27%
(-0,090) 1D
1,34 USD
0,00% (0,00)
After hours
Closed: 12-окт., 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNGO...
Open
1,41 USD
High
1,42 USD
Low
1,29 USD
Mkt. cap
15,79 млн
Avg. vol.
1,83 млн
Volume
487,70 миң
52-wk high
2,23 USD
52-wk low
1,00 USD
EPS
-3,76 USD
Beta
1,66
Shares outstanding
11,78 млн
No. of employees
96
Open
1,41 USD
High
1,42 USD
Low
1,29 USD
Mkt. cap
15,79 млн
Avg. vol.
1,83 млн
Volume
487,70 миң
52-wk high
2,23 USD
52-wk low
1,00 USD
EPS
-3,76 USD
Beta
1,66
Shares outstanding
11,78 млн
No. of employees
96
News stories
From web sources and news partners
About BioNano Genomics Inc
CEOErik Holmlin
Employees96
Founded2003
HeadquartersСан Диего, Калифорния, Америка Кошмо Штаттары
SectorHealth care
Websitebionano.com
Analyst ratings
Based on 1 analyst giving stock ratings to BNGO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BNGO in the last 3 months
Highest
Current 1,34 USD
4,00 USD (+197,40%)
Average
4,00 USD (+197,40%)
Lowest
4,00 USD (+197,40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
4,00 USD
+197,4%
09/10/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
6,00 USD
+346,1%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
7,37 млн
7,95 млн
6,69 млн
8,17 млн
Cost of goods sold
4,00 млн
4,55 млн
3,44 млн
3,86 млн
Cost of revenue
4,00 млн
4,55 млн
3,44 млн
3,86 млн
Research and development expenses
2,84 млн
3,23 млн
3,14 млн
2,99 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,06 млн
8,71 млн
8,01 млн
8,54 млн
Operating expense
11,91 млн
11,94 млн
11,15 млн
11,53 млн
Total operating expenses
15,90 млн
16,49 млн
14,58 млн
15,39 млн
Operating income
-8,54 млн
-8,54 млн
-7,90 млн
-7,22 млн
Other non operating income
-150,00 миң
434,00 миң
-547,00 миң
-274,00 миң
EBT including unusual items
-8,49 млн
-7,90 млн
-8,29 млн
-7,42 млн
EBT excluding unusual items
-8,49 млн
-7,90 млн
-8,29 млн
-7,42 млн
Income tax expense
14,00 миң
35,00 миң
10,00 миң
7,00 миң
Effective tax rate
-0,16%
-0,44%
-0,12%
-0,09%
Other operating expenses
-
-
-
-
Net income
-8,50 млн
-7,93 млн
-8,30 млн
-7,42 млн
Net profit margin
-115,42%
-99,77%
-124,17%
-90,85%
Earnings per share
-1,59
-0,03
-0,75
-0,60
Interest and investment income
268,00 миң
276,00 миң
223,00 миң
146,00 миң
Interest expense
-69,00 миң
-72,00 миң
-72,00 миң
-70,00 миң
Net interest expenses
199,00 миң
204,00 миң
151,00 миң
76,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,11 млн
-6,15 млн
-5,54 млн
-4,87 млн
Gain or loss from assets sale
-
-
34,00 миң
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору